AAV8 Serotype
Highly efficient liver-tropic serotype widely used in clinical hepatic gene therapy. Discovered from rhesus macaque tissue. Superior liver transduction versus AAV2.
| Tropism | Liver (primary), muscle, CNS (moderate), pancreas |
|---|
Characteristics
10-100 fold higher liver transduction than AAV2. Fast onset of transgene expression (1-2 weeks). Moderate pre-existing immunity (~40% seropositive). Uses laminin receptor (LamR) for hepatocyte binding. Efficient hepatocyte transduction at low doses. Good safety profile in clinical trials.
Applications
Hemophilia A and B gene therapy (multiple clinical trials). Liver-directed metabolic disorders. Ornithine transcarbamylase deficiency. Glycogen storage diseases. Acute intermittent porphyria. Most common serotype for liver gene therapy trials.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Nathwani et al. (2011). Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med — Nathwani 2011 Hemophilia B
